These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 1332849)

  • 61. Androgens augment vasoactive intestinal peptide- and growth hormone-releasing hormone-stimulated progestin production by rat granulosa cells.
    Li YD; Kasson BG
    Endocrinology; 1993 Feb; 132(2):584-90. PubMed ID: 8425478
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isolation of human Leydig cells which are highly responsive to human chorionic gonadotropin.
    Simpson BJ; Wu FC; Sharpe RM
    J Clin Endocrinol Metab; 1987 Sep; 65(3):415-22. PubMed ID: 3114298
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cellular localization of rat testicular aromatase activity during development.
    Tsai-Morris CH; Aquilano DR; Dufau ML
    Endocrinology; 1985 Jan; 116(1):38-46. PubMed ID: 2981072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of human chorionic gonadotropin derivatives on leydig cell function.
    Ronco AM; Llanos MN
    Horm Res; 2000; 54(4):157-63. PubMed ID: 11416231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
    Shima K; Sakakibara H; Said SI
    Regul Pept; 1996 Jul; 63(2-3):99-103. PubMed ID: 8837217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
    Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LH action in the Leydig cell: modulation by angiotensin II and corticotropin releasing hormone, and regulation of P450(17) alpha mRNA.
    Dufau ML; Ulisse S; Khanum A; Buczko E; Kitamura M; Fabbri A; Namiki M
    J Steroid Biochem; 1989; 34(1-6):205-17. PubMed ID: 2696845
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of carbohydrate of human chorionic gonadotropin in the mechanism of hormone action.
    Moyle WR; Bahl OP; März L
    J Biol Chem; 1975 Dec; 250(23):9163-9. PubMed ID: 172504
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gonadotropin binding and stimulation of cyclic adenosine 3':5'-monophosphate and testosterone production in isolated Leydig cells.
    Mendelson C; Dufau M; Catt K
    J Biol Chem; 1975 Nov; 250(22):8818-23. PubMed ID: 171267
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modulation of mouse Leydig cell steroidogenesis through a specific arginine-vasopressin receptor.
    Tahri-Joutei A; Pointis G
    Life Sci; 1988; 43(2):177-85. PubMed ID: 2455854
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Gonadotropin stimulation of cyclic adenosine monophosphate and testosterone production without detectable high-affinity binding sites in purified Leydig cells from rat testis.
    Browne ES; Bhalla VK
    Steroids; 1991 Feb; 56(2):83-90. PubMed ID: 1850564
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of functional leptin receptors in rodent Leydig cells.
    Caprio M; Isidori AM; Carta AR; Moretti C; Dufau ML; Fabbri A
    Endocrinology; 1999 Nov; 140(11):4939-47. PubMed ID: 10537117
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH in vitro.
    Chen H; Hardy MP; Zirkin BR
    Endocrinology; 2002 May; 143(5):1637-42. PubMed ID: 11956144
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hormonal regulation of beta-endorphin in the testis.
    Fabbri A; Dufau ML
    J Steroid Biochem; 1988; 30(1-6):347-52. PubMed ID: 2838695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis.
    El-Gehani F; Zhang FP; Pakarinen P; Rannikko A; Huhtaniemi I
    Biol Reprod; 1998 Jan; 58(1):116-23. PubMed ID: 9472931
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fetal Leydig cell culture--an in vitro system for the study of trophic hormone and GnRH receptors and actions.
    Dufau ML; Knox GF
    J Steroid Biochem; 1985 Nov; 23(5B):743-55. PubMed ID: 3001417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide inhibit tumor proliferation by different mechanisms: evidence from in vitro studies on human prostatic and pancreatic cancers.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Armatis P; Groot K; Czompoly T
    Endocrinology; 2000 Jun; 141(6):2120-8. PubMed ID: 10830299
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1.
    Heinrich N; Meyer MR; Furkert J; Sasse A; Beyermann M; Bönigk W; Berger H
    Endocrinology; 1998 Feb; 139(2):651-8. PubMed ID: 9449637
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.